Zealand Pharma Drug Patent Portfolio

Zealand Pharma owns 2 orange book drugs protected by 2 US patents Given below is the list of Zealand Pharma's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10442847 Glucagon analogues 03 Feb, 2035
Active
US11795204 Glucagon analogues 06 Jan, 2034
Active


Given below is the list of recent legal activities going on the following drug patents of Zealand Pharma.

Activity Date Patent Number
Patent litigations
Mail Patent eCofC Notification 25 Jun, 2024 US11795204
Recordation of Patent eCertificate of Correction 25 Jun, 2024 US11795204
Patent eCofC Notification 25 Jun, 2024 US11795204
Email Notification 25 Jun, 2024 US11795204
Mail Patent eCofC Notification 25 Jun, 2024 US11795204
Email Notification 25 Jun, 2024 US11795204
Recordation of Patent eCertificate of Correction 25 Jun, 2024 US11795204
Patent eCofC Notification 25 Jun, 2024 US11795204
Post Issue Communication - Certificate of Correction 05 Jun, 2024 US11795204
Post Issue Communication - Certificate of Correction 05 Jun, 2024 US11795204
transaction for FDA Determination of Regulatory Review Period 30 Nov, 2023 US10442847
transaction for FDA Determination of Regulatory Review Period 30 Nov, 2023 US10442847
Patent Issue Date Used in PTA Calculation 24 Oct, 2023 US11795204
Email Notification 24 Oct, 2023 US11795204
Recordation of Patent eGrant 24 Oct, 2023 US11795204


Zealand Pharma's Family Patents

Zealand Pharma drugs have patent protection in a total of 24 countries. It's US patent count contributes only to 14.7% of its total global patent coverage. Click below to unlock the full patent family tree.

Family Patents



Zealand Pharma Drug List

Given below is the complete list of Zealand Pharma's drugs and the patents protecting them.


1. Zegalogue

Zegalogue is protected by 2 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10442847 Glucagon analogues 03 Feb, 2035
(10 years from now)
Active
US11795204 Glucagon analogues 06 Jan, 2034
(9 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zegalogue's drug page


2. Zegalogue (autoinjector)

Zegalogue (autoinjector) is protected by 2 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10442847 Glucagon analogues 03 Feb, 2035
(10 years from now)
Active
US11795204 Glucagon analogues 06 Jan, 2034
(9 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zegalogue (autoinjector)'s drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List